Walgreens Boots Alliance (NASDAQ:WBA) issued its quarterly earnings data on Wednesday. The pharmacy operator reported $1.22 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.03 by $0.19, MarketWatch Earnings reports. Walgreens Boots Alliance had a net margin of 0.33% and a return on equity of 18.33%. The company had revenue of $36.31 billion during the quarter, compared to the consensus estimate of $35.01 billion. During the same quarter last year, the company earned $1.37 earnings per share. Walgreens Boots Alliance’s revenue for the quarter was up 5.7% on a year-over-year basis.
WBA stock opened at $45.26 on Friday. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.32 and a current ratio of 0.67. The stock has a market capitalization of $39.10 billion, a price-to-earnings ratio of 90.52, a PEG ratio of 1.52 and a beta of 0.44. Walgreens Boots Alliance has a 1 year low of $33.36 and a 1 year high of $56.80. The stock’s fifty day moving average is $40.18 and its two-hundred day moving average is $39.23.
The company also recently disclosed a quarterly dividend, which was paid on Friday, December 11th. Investors of record on Thursday, November 19th were paid a dividend of $0.4675 per share. This represents a $1.87 annualized dividend and a yield of 4.13%. The ex-dividend date of this dividend was Wednesday, November 18th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 39.45%.
WBA has been the subject of several recent research reports. Truist Financial increased their price objective on shares of Walgreens Boots Alliance from $40.00 to $44.00 in a research report on Tuesday. Bank of America reaffirmed a “sell” rating and issued a $37.00 price objective on shares of Walgreens Boots Alliance in a research report on Wednesday, October 7th. Zacks Investment Research raised shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating and set a $39.00 price objective for the company in a research report on Saturday, November 7th. Barclays lowered their price objective on shares of Walgreens Boots Alliance from $45.00 to $40.00 and set an “equal weight” rating for the company in a research report on Thursday, October 8th. Finally, BidaskClub downgraded shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research report on Friday, December 18th. Four investment analysts have rated the stock with a sell rating and fourteen have given a hold rating to the company. The company has an average rating of “Hold” and a consensus price target of $41.07.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and beauty retail company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.